Institute of Experimental Medicine AS CR, v. v. i. › Institute › EU Structural Funds Projects › Running Projects
The project CZ.2.16/3.1.00/21527 is financed by the European Regional Development Fund and public budgets of the Czech Republic through the Operational Programme Prague – Competitiveness, which is managed by Prague City Hall.
Duration: 1/2014 – 9/2014.
Operational Programme |
Operational Programme Prague – Competitiveness (OPPC) |
Priority axis |
3. Innovation and Business Enterprise |
Support area |
3.1 Development of innovation environment and partnership between the research and development base and practice |
Call number |
11 |
Registration number |
CZ.2.16/3.1.00/21527 |
Duration |
1st January 2014 – 30 th September 2014 |
Approved Eligible Investment Costs |
16.600.000,00 CZK (approx. 604.000,- EUR) |
Project
team
|
Bc. Ján Říha, project manager Ing. Jiří Peroutka, financial manager RNDr. Jan Malínský, Ph.D., expert |
The purpose of the project is to establish the Laboratory for Advanced Bioimaging of Living
Tissues and to provide it with technology consisting of:
• an upright confocal microscope for direct observation in an aqueous medium
• a fast monochromator for multi-frequency excitation of fluorescence
The acquisition of the mentioned technology is a precondition for sustaining the competitiveness
of the Institute of Experimental Medicine AS CR (IEM AS CR) and its partners on the international
level. Furthermore, it increases the chance of obtaining new grant funding both from national and
international sources.
By acquiring new technology the IEM AS CR is able to maintain its technological background on a
level comparable to other similar research institutions in the world and to establish a new
specialised facility focused on researching selected aspects of the incidence and progress of
neurodegenerative diseases (Alzheimer disease, Parkinson disease, multiple sclerosis,
cerebrovascular accidents) as well as the complications associated with posttraumatic states (brain
and spinal cord injuries, posttraumatic edema, epilepsy) via advanced imaging methods.
From 2010 to 2011, experiments planned within the scope of the research projects carried out at the IEM AS CR used the current inverted confocal microscope. Test results were clear: the setting of an inverted microscope is utterly unsuitable for the planned measurement of tissue sections in a medium of which the composition is manipulated during the experiment. The experiments were postponed as they are momentarily impracticable.
Progress and Current Status of the Project Implementation
During January and February 2014, documentation was prepared for the public tender for the
supply of the necessary technologies, i.e.: the confocal microscope and the monochromator. The
public tender was divided into two parts. The tender documentation was available on the website of
the Operational Programme Prague – Competitiveness (OPPC) and in the on-line journal of public
tenders. The documents were published on the website of the OPPC on Friday, 21st February 2014. The
opening of envelopes took place on Monday, 14th April 2014 at 1.00 p.m. in the building of the IEM
AS CR. In the first part of the public tender the offer submitted by Olympus Czech Group, s.r.o.
was chosen as the winning bid. The purchase contract was signed on 19th May 2014.
The second part of the public tender had to be cancelled, as only one offer had been submitted. It was therefore necessary to arrange the second part of the public tender again. The tender documentation of the repeated public tender was published on the website of the OPPC on Friday, 2nd May 2014. The opening of envelopes took place on Tuesday, 24th June 2014 at 1.00 p.m. in the building of the IEM AS CR. The offer submitted by Carl Zeiss spol. s r.o. was selected as the winning bid and the purchase contract was signed on 21st July 2014. Both devices are to be delivered during August 2014.
1 Apr 2014